Individual

Environment

Society

Markets

Geopolitics

Considerations for Investors

Hardware and software advancements, including data-driven solutions, can revolutionize patient care and drive operational efficiency. The emergence of genetic modification technology holds promise for targeted treatments and personalized medicine. Nevertheless, the potential for misuse is extensive and ethical considerations matter for several reasons. First, regulatory and legal challenges surrounding data privacy and genetic modification can impact the profitability and sustainability of healthcare investments. Non-compliance with privacy regulations can result in significant fines and reputational damage. Additionally, negative societal perceptions of companies engaged in unethical practices can harm investor confidence and shareholder value. By proactively addressing ethical risks through governance structures that embed responsible innovation, prudent healthcare companies can mitigate compliance exposure, build trust with stakeholders, and distinguish their brands.

Shop Now

Things Happening in this Space

View All
Screenshot 2025-01-11 at 17-23-11 Robots learn surgical tasks by watching videos - The Washington Post
organisms-beyond-life-death
6564186567a047
Screenshot 2024-12-14 165940
AP24129567862668
11AI-CRISPR-VIDEO-COVER2-superJumbo
gettyimages-1211994928-b2102e34cbd7f03b4e62a7fb52b0a156da9383ca-s1200-c85
download (6)
11tumors-superJumbo
00RemoteWorkEffects-kcqv-superJumbo
Jamie-Dimond-1_0
download (13)

Stay in Touch

Keep up to date with all the latest news, insights and ideas

Linkedin-in Youtube

© Copyright 2024 Creating Future Us. All Rights Reserved. Please note our IP Terms of Business for the production, purchase or use of any CFU IP and Materials.

Creating Future Us is the Not-for-Profit arm of Paradigm Change Capital Partners LLP

Healthcare - Individual

The key individual impacts of concern for investors are:  

 

Safety: Patient-facing and operational hardware require rigorous safety testing, quality control, and cybersecurity protections due to potentially life-threatening risks.

 

Privacy: The vast aggregation of sensitive patient data through building access systems, biometrics, electronic medical records, and IoT devices warrants clear consent permissions, transparent retention policies, access controls,, and compliance with regulations to prevent abuse and unauthorized access.

 

Unless the above are proactively addressed, potential ramifications include:

 

  • Lawsuits, fines, and eroded patient trust if technologies are seen to cause harm or violate privacy.

Healthcare - Environment

The key environmental impacts of concern for investors are: 

 

Sustainability: Health systems and suppliers optimizing energy efficiency, adopting greener chemistries, and improving electronics recycling can help to reduce the sector’s environmental footprint.

 

Responsible sourcing:  The broad supply chain in the sector creates risks around exploitative labor, the use of dangerous materials, counterfeit components or instruments enabling flawed research. Third-party vendor audits, supplier codes of conduct, and responsible sourcing policies can mitigate these risks.

 

Unless the above are proactively addressed, potential ramifications include:

 

  • Fines due unsustainable procurement, materials usage, and waste disposal.

 

Supply chain disruptions from climate impacts absent ethical sourcing.

Healthcare - Society

The key societal impacts of concern for investors are:

 

Transparency: Lack of visibility into proprietary diagnostic algorithms, data practices, and complex analytics reduces accountability. Transparency in their use is crucial.

 

Responsible AI: AI systems can exhibit biases and deficiencies. Testing unproven AI in high-risk clinical settings before deployment is essential for patient safety.

 

Clinical Decision Biases: Flawed algorithms and skewed training data in patient triaging, diagnostic support, or bed allocation may result in discriminatory treatment if not addressed during design.

 

Harmful Use: CRISPR gene editing, viral engineering, or chemical synthesis software may be misused without proper governance and oversight.

 

Health Equity: Aggregated genomic and clinical data may concentrate on advances instead of promoting inclusive innovation across regions and socioeconomic conditions.

 

Unless the above are proactively addressed, potential ramifications include:

 

  • Remediation costs from breaches exposing sensitive personal health data.
  • Increased regulatory burden to ensure the oversight of algorithms involved in determining patient outcomes.

Healthcare - Markets

The key market impacts of concern for investors are:

 

Regulatory lag: Advances like human germline editing, synthetic biology, and biopharming may outpace regulatory preparedness if not adaptively governed with prudence. International guidelines and oversight are still evolving.

 

Conflict of interest: Ensuring that data, insights and research are independently verified ensures that medical ethics are followed and not skewed by partisan interest groups. 

 

Vendor ethics: The widespread use of external cloud providers and analytics partners necessitates governance considerations to ensure a continued focus on algorithmic fairness, data privacy and fostering trust despite increased outsourcing of critical health functions.

 

Unless the above are proactively addressed, potential ramifications include:

 

  • Noncompliance costs from evolving regulations around data, AI, privacy.

 

Costs and risks relating to deploying innovations without       established governance procedures.

Healthcare - Geopolitics

The key geopolitical impacts of concern for investors are:

 

Cybersecurity: Inadequate encryption and security in medical devices, research facilities, and hospital equipment pose operational technology risks if breached. Interconnectivity risks ransomware, denial of service, and system sabotage attacks, endangering continuity of care. Comprehensive strategies across software infrastructure layers are vital.

 

Biological weapons: Innovative biotech, such as gene editing techniques, could enable the development of biological weapons. Caution and regulation of this area is key.

 

Unless the above are proactively addressed, potential ramifications include:

 

  • Disruption, extortion, and remediation costs from state-sponsored hacking.
  • Reputational and liability risks if technologies are used unethically by regimes.

 

Heightened regulatory scrutiny of the sector due to the geopolitical sensitivity of new biotech.